Sandbox:Shalinder: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==




Line 13: Line 12:
**bbb
**bbb
**#ccc
**#ccc
**#ffff
**#ffff<ref name="pmid16815157">{{cite journal |vauthors=Williams H, Flohr C |title=How epidemiology has challenged 3 prevailing concepts about atopic dermatitis |journal=J. Allergy Clin. Immunol. |volume=118 |issue=1 |pages=209–13 |date=July 2006 |pmid=16815157 |doi=10.1016/j.jaci.2006.04.043 |url=}}</ref>




Line 40: Line 39:
|
|
|}
|}


==Signs and Symptoms==
==Signs and Symptoms==
Line 108: Line 106:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
<ref name="pmid29121124">{{cite journal| author=Silverberg NB| title=Atopic dermatitis prevention and treatment. | journal=Cutis | year= 2017 | volume= 100 | issue= 3 | pages= 173;177;192 | pmid=29121124 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29121124  }} </ref>
 


<ref name="pmid29121124">Silverberg NB (2017) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=29121124 Atopic dermatitis prevention and treatment.] ''Cutis'' 100 (3):173;177;192. PMID: [https://pubmed.gov/29121124 29121124]</ref>
<ref name="pmid29121124">Silverberg NB (2017) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=29121124 Atopic dermatitis prevention and treatment.] ''Cutis'' 100 (3):173;177;192. PMID: [https://pubmed.gov/29121124 29121124]</ref>
<references />

Revision as of 15:44, 26 September 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shalinder Singh, M.B.B.S.[2]

Overview

Pathophysiology

Pathogenesis

  • aaaa
    • bbb
      1. ccc
      2. ffff[1]


Physiology

sdlkchadklsh gsdcdhfds
type type 1
type 2

Signs and Symptoms

Following are the signs and symptoms of Lyme disease.

ksadkasdlknasd

sadjkasdkj
dfnlkjdflkjasljdfl

  • jkajsda
  • jfdkkajsdf
    • jdfskajfd
      • dfaskjd
    1. dbfksdf
      • odhfsd
      1. jkfsad
asdkjalkjd
aksjdhas
salkasdas
sakjdnlka
jasndsan
sajkdas
askdnlak
  • sdjfnsd
  • ldskasd
    • sakjlldja
      • aslkdj
        askjda
        1. sadkjh
        2. sdjlas
          sajd
          1. sjda

11111 2222222222 333333333333 44444444444 55555555555 66666666666

This is the center text only.

Above line


Below line


This should be in bold


This should be in italics


This should be in both bold and italics

This is my quote!! - Shalinder Singh

I am writing in blue

This is a 10


S.Singh (talk)

S.Singh (talk) 15:49, 25 September 2018 (UTC)

15:49, 25 September 2018 (UTC)


References

  1. Williams H, Flohr C (July 2006). "How epidemiology has challenged 3 prevailing concepts about atopic dermatitis". J. Allergy Clin. Immunol. 118 (1): 209–13. doi:10.1016/j.jaci.2006.04.043. PMID 16815157.

Silverberg NB (September 2017). "Atopic dermatitis prevention and treatment". Cutis. 100 (3): 173, 177, 192. PMID 29121124.

References


[1]

  1. Silverberg NB (2017) Atopic dermatitis prevention and treatment. Cutis 100 (3):173;177;192. PMID: 29121124